TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+64.7%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$229M
AUM Growth
+$229M
(-6.3%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-44.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Pliant Therapeutics
PLRX
|
$41.8M |
| 2 |
Revolution Medicines
RVMD
|
$29.6M |
| 3 |
Nurix Therapeutics
NRIX
|
$24.4M |
| 4 |
Voyager Therapeutics
VYGR
|
$5.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pliant Therapeutics
PLRX
$103M
| $80.2M | 35.02% |
3,839,160
-2,000,000
| -34% | -$41.8M |
|
|
2
Revolution Medicines
RVMD
$7.39B
| $71.1M | 31.03% |
3,604,130
-1,500,000
| -29% | -$29.6M |
|
|
3
Voyager Therapeutics
VYGR
$199M
| $32.1M | 14.03% |
5,428,933
-962,243
| -15% | -$5.7M |
|
4
Fulcrum Therapeutics
FULC
$347M
| $32.1M | 14% |
3,962,202
| – | – |
|
|
DBTX
5
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $10.9M | 4.74% |
3,139,685
| – | – |
|
|
JNCE
6
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.69M | 1.17% |
1,148,780
| – | – |
|
|
7
Nurix Therapeutics
NRIX
$696M
| – | – |
-1,922,549
| Closed | -$24.4M |
|